Market Overview:
The global finasteride tablets market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of benign prostatic hyperplasia (BPH) and male pattern baldness (MPB) and the rising demand for effective and safe treatments for these conditions. Finasteride is a drug that is used for the treatment of BPH, MPB, and other conditions. It is available in two formulations: 1 mg tablet and 5 mg tablet. The 1 mg tablet formulation is used for the treatment of BPH, while the 5 mg tablet formulation is used for the treatment of MPB and other conditions. The global finasteride tablets market has been segmented on the basis of type, application, and region. On the basis of type, it has been segmented into 1 mg tablet and 5 mg tablet formulations. On the basis of application, it has been segmented into BPH, MPB, alopecia areata (AA), female pattern hair loss (FPHL), hirsutism & idiopathic intracranial hypertension (IIH), prostate cancer prevention & others). Geographically, it has been segmented into North America,, Latin America,, Europe,, Asia Pacific,, Middle East & Africa,.
Product Definition:
Finasteride tablets are used to treat male pattern baldness, also known as androgenetic alopecia. They work by preventing the body from converting testosterone into a hormone called dihydrotestosterone (DHT), which is responsible for hair loss in men.
1mg Tablet:
1mg tablet is a generic name for the drug used to treat prostate cancer. It belongs to the category of drugs called as Androgen Deprivation Therapy (ADT). Prostate cancer is one of the most common types of cancers in men, globally. According to WHO, around 6 million cases are diagnosed every year and it's estimated that there would be about 14 million new cases each year by 2030.
5mg Tablet:
5mg tablet is used for the treatment of prostate cancer. It works by lowering levels of a certain type of blood protein called eugonadotrophic factor in the body. Finasteride tablets are also used to treat breast cancer and hair loss (alopecia).
The drug was approved by the U.
Application Insights:
Male pattern baldness was the most prominent application segment in terms of demand and is expected to witness a CAGR of XX% from 2018 to 2030. Finasteride tablets are FDA approved for the treatment of male pattern baldness and are available in generic form as well. The drug has been proven effective for this purpose through various clinical trials and is therefore expected to gain wide acceptance for this indication over the forecast period.
Benign prostate hyperplasia or BPH is another major application area where finasteride finds considerable usage owing to its ability to reduce prostate size without causing any significant side effects compared to other drugs used for treating BPH such as Dutasteride & Avodart which have lesser efficacy than Finpecia (Finacea).
Regional Analysis:
North America dominated the global market in 2017. The high prevalence of hair loss and prostate related problems such as BPH, bladder obstruction, urinary retention along with rising awareness about available treatment options are some factors responsible for its largest share. In addition, increasing R&D activities by various companies to develop novel formulations is expected to fuel the growth over the forecast period.
Asia Pacific is anticipated to be one of the fastest growing regions during the forecast period owing to a large population base suffering from hair loss and prostate related disorders coupled with improving healthcare infrastructure in emerging countries such as China and India will drive industry growth over next eight years. Moreover, increasing disposable income levels in these countries will also have positive impacts on regional demand during same period due to rise adoption of western culture resulting into increased consumption of finasteride tablets among men aged 18-70 years old group which has highest incidence rate for prostatic diseases including BPH & urinary retention etc., thus positively influencing overall revenue generation capacity throughout forecast horizon.
Growth Factors:
- Increasing awareness about hair loss and its treatment options among people, especially men
- Growing demand for effective and affordable hair loss treatments
- Rising prevalence of baldness and thinning hair in men
- Proliferation of online marketing channels for Finasteride Tablets products 5. Growing number of male-focused beauty clinics
Scope Of The Report
Report Attributes
Report Details
Report Title
Finasteride Tablets Market Research Report
By Type
1mg Tablet, 5mg Tablet
By Application
Benign Prostatic Hyperplasia, Male Pattern Baldness, Others
By Companies
Merck, Actavis, Sandoz, Teva Pharmaceuticals, Cipla, RelonChem, Dr. Reddy, Accord Pharmaceuticals, Henan Topfond, Zhejiang CONBA Pharmaceutical, Merck, Guangdong Eashu Pharmacetical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
215
Number of Tables & Figures
151
Customization Available
Yes, the report can be customized as per your need.
Global Finasteride Tablets Market Report Segments:
The global Finasteride Tablets market is segmented on the basis of:
Types
1mg Tablet, 5mg Tablet
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Benign Prostatic Hyperplasia, Male Pattern Baldness, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck
- Actavis
- Sandoz
- Teva Pharmaceuticals
- Cipla
- RelonChem
- Dr. Reddy
- Accord Pharmaceuticals
- Henan Topfond
- Zhejiang CONBA Pharmaceutical
- Merck
- Guangdong Eashu Pharmacetical
Highlights of The Finasteride Tablets Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 1mg Tablet
- 5mg Tablet
- By Application:
- Benign Prostatic Hyperplasia
- Male Pattern Baldness
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Finasteride Tablets Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Finasteride tablets are a medication used to treat male pattern baldness. They work by reducing the production of testosterone in the body.
Some of the key players operating in the finasteride tablets market are Merck, Actavis, Sandoz, Teva Pharmaceuticals, Cipla, RelonChem, Dr. Reddy, Accord Pharmaceuticals, Henan Topfond, Zhejiang CONBA Pharmaceutical, Merck, Guangdong Eashu Pharmacetical.
The finasteride tablets market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Finasteride Tablets Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Finasteride Tablets Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Finasteride Tablets Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Finasteride Tablets Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Finasteride Tablets Market Size & Forecast, 2020-2028
4.5.1 Finasteride Tablets Market Size and Y-o-Y Growth
4.5.2 Finasteride Tablets Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 1mg Tablet
5.2.2 5mg Tablet
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Benign Prostatic Hyperplasia
6.2.2 Male Pattern Baldness
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Finasteride Tablets Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Finasteride Tablets Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 1mg Tablet
9.6.2 5mg Tablet
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Benign Prostatic Hyperplasia
9.10.2 Male Pattern Baldness
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 1mg Tablet
10.6.2 5mg Tablet
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Benign Prostatic Hyperplasia
10.10.2 Male Pattern Baldness
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 1mg Tablet
11.6.2 5mg Tablet
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Benign Prostatic Hyperplasia
11.10.2 Male Pattern Baldness
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 1mg Tablet
12.6.2 5mg Tablet
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Benign Prostatic Hyperplasia
12.10.2 Male Pattern Baldness
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 1mg Tablet
13.6.2 5mg Tablet
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Benign Prostatic Hyperplasia
13.10.2 Male Pattern Baldness
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Finasteride Tablets Market: Competitive Dashboard
14.2 Global Finasteride Tablets Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck
14.3.2 Actavis
14.3.3 Sandoz
14.3.4 Teva Pharmaceuticals
14.3.5 Cipla
14.3.6 RelonChem
14.3.7 Dr. Reddy
14.3.8 Accord Pharmaceuticals
14.3.9 Henan Topfond
14.3.10 Zhejiang CONBA Pharmaceutical
14.3.11 Merck
14.3.12 Guangdong Eashu Pharmacetical
